Week 363 Review - Quite a good week spoiled by an Optibiotix dip

This would have been quite a good week, but a 2.5p drop in OPTI:Optibiotix spoiled everything else and the deficit between cost and value widened by £3,850 to £78,292. Total value fell to £105,134, but at the moment as long as it's above £100k then I'm happy.

Biggest fallers were only 5%. The first of these was AJB:AJ Bell which I only bought on Friday but it dropped afterwards and there's also spread. Not a great start to my latest magic formula share.

SBTX:SkinBioTherapeutics also fell 5% in my SIPP for no reason other than drift because nothing seems to be happening.

I don't usually mention rises of less than 5%, but PLUS:Plus500 climbed 4% and is now in profit by 2%. I have so few things in profit I figured it was worth celebrating. It's only £24 up, but I've also had £47 in dividends. I'm past my 12 month review period, but as it still appears in my top 30 magic formula shares using the new ranking system, I've clocked on the review date by 12 months.

CEY:Centamin climbed by 6% but is still 31% down. This is another magic formula share that's past the 12 month review date but still in the top 30, so again I've clocked on the review date another year.

TLOU:Tlou Energy went up 7%. It may have been caused by photos of the breaking ground ceremony for the electricity transmission lines. This demonstrates that they really are going ahead with the project and when it's finished there should be a huge amount of revenue. For now they are still 47% down.

JLP:Jubilee Metals had the biggest rise this week of 9%, but I'm not giving it Share of the Week because it's 9% of my purchase price which is a much smaller percentage rise of the current price. I'm still going to measure percentage change based on my purchase price though, as keeping a snapshot of last week's price to measure the rise is too much effort.

IGG:IG Group climbed 8% after really good results, but they are still 12% down from when I bought them. They are also still in my top 30 magic formula shares, so their review date has also clocked on 12 months.

Share of the week is CAML:Central Asia Metals because they climbed 8% to go back into profit, and it's just after I doubled the size of my holding so I'm very happy with them. Although they are in my top 30 magic formula ranking, I'm not going to treat them as a magic formula share as I like them too much. I'll keep adding more and build my holding back up to what it was a few years ago.

Managed to stay just above the injection line.

Hopefully just a little dip as people take OPTI:Optibiotix trading profits.

Here's the ISA and shares portfolio after week 51 of year 7.

			Weekly Change
Cash	£100		+£100
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£46,259.27	(-44.2%)	-£2,198.34
Potential profits	£1,217.55		+£54.00
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,219.68	(33.0%)	-£24.39
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£472.01	(12.8%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Cash is up £100 as I had none to pay fees so opened a new ISA for the tax year with £100. Potential profits up £54 thanks to JLP:Jubilee Metals, and £2,198 drop in value thanks to OPTI:Optibiotix. Next week marks the end of year 7 which will look better than it actually was thanks to the big share dividend when PBX:Probiotix was spun out.

As with the combined chart, we're just above the injection line

Looks a bit steeper than the dip on the combined chart.

The SIPP looks like this after week 347 overall and week 35 of year 7.

			Weekly Change
Cash	£103.73		+£28.06
Portfolio cost	£98,389.93		+£3.96
Portfolio sell value (bid price - commission)	£57,907.77	(-41.1%)	-£1,666.11
Potential profits	£86.08		+£86.08
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0.01
Yr 7 Profit from sales	£275.31		+£32.00
Yr 7 projected avg monthly profit	£1,346.85	(28.9%)	-£35.58
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0.01
Total Profit from sales	£23,999.94		+£32.00
Average monthly cash profit	£461.87	(9.9%)	-£0.94
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	66%		+0%

Potential profits are up £96, some of which was PLUS:Plus500 and some of which was CAML:Central Asia Metals. Much excitement with a 1p interest payment!

I sold my shares in DNLM:Dunelm Group because they were outside the top 30 magic formula shares using my new ranking method, so it was a mistake to buy them a few weeks ago. Seeing as they popped into profit I sold my 121 shares at 872.0062p making £32 (3.6%) profit.

As I mentioned in the intro, I re-invested in AJB:AJ Bell which is in the top 30 magic formula shares and is also on an ascending trajectory, as another rule for my magic formula shares is never to buy them if they are on their way down. I've learnt from my mistakes with that one - on many occasions! I bought 325 shares at 307.1359p costing £1,015.13 with commission and stamp duty.

Total value dropped £1,666 but long term performance still looking good, at least until DDDD:4D Pharma go bust at which point it will be dreadful.

Same as the other charts

Slightly less steep drop than the ISA

The trading account looks like this after week 313 overall and week 1 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£721.00	(-61.6%)	+£13.92
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.97	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

We start year 7 this week so thankfully all the huge negatives from year 6 have gone back to zero. Potential profits went up by £13 thanks to JLP:Jubilee Metals so I'm hoping that means the big seller has stopped, as it was just typical that this should happen the week after I bought them for my trading account!

Still desperately bad

I like this chart more!

There's a sense of excitement in the OPTI:Optibiotix camp like I've not seen before. After 7 years of mostly misery it looks as if there will be a run of big announcements through the rest of this year. I thought Sweetbiotix was our holy grail, but it's looking like the microbiome modulators could be even bigger. That's astonishing because Sweetbiotix is going to be huge. It's been a long wait, but if everything pans out as hoped, it will have been worth it.

Week 362 Review - Optibiotix continues a gradual recovery with another great week

Two great weeks in a row. It's been well over a year since I could say that. OPTI:Optibiotix continued to recover with a 6.5p gain and was the main cause of a £12,081 reduction in the deficit between cost and value to £74,441 and I'm very happy to say took the overall portfolio value back over £100k to £108,853.

Biggest faller was JLP:Jubilee Metals, which goes without saying as I bought them in my  cursed trading account. It turns out a major investor who received shares as part of a debt arrangement is offloading them at a huge profit. Thankfully the impact could be a lot worse, but my trading account dropped by 5% and my main holding by 16% of my purchase price.

ASHM:Ashmore Group fell another 5% presumably because they have lots of links with China. These are 32% down and have been a magic formula disaster.

Another magic formula disaster is CEY:Centamin which dropped another 5% to go 37% down.

SBTX:SkinBioTherapeutics climbed 5% on no news but are still 43% down.

Share of the Week for a second week n a row is OPTI:Optibiotix which climbed 11% and is now only 38% down. Could break even in 4 weeks if we keep this rate up. The news propelling the share price higher this week was a deal with Firmenich who are one of the world's biggest sweetener suppliers, and also publication of a paper in the Journal of Agricultural and Food Chemistry titled "Prebiotic potential of a new sweetener based on galactooligosaccharides and modified mogrosides". Both announcements have been long-awaited and could propel the share price back to the 60p range which would allow me to at least be breaking even.

Back above the injection line - much joy!

Soaring above the trend line now, but a long way from dragging it flat.

Here's the ISA and shares portfolio after week 50 of year 7.

			Weekly Change
Cash	£0		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£48,457.61	(-41.6%)	+£5,973.46
Potential profits	£1,163.55		-£94.50
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,244.07	(33.8%)	-£25.39
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£473.32	(12.8%)	-£1.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Potential profits down £94 thanks to the drop in JLP:Jubilee Metals but value up by almost £6k and with just 2 weeks to go to the end of year 7, it's looking like an excellent long term performance. However, we mustn't forget that looks good because it includes the PBX:Probiotix shares as a dividend. Next year could look really bad if DDDD:4D Pharma go bust.

Nicer than 2 weeks ago.

Way above the trend line, but can it last?

The SIPP looks like this after week 346 overall and week 34 of year 7.

			Weekly Change
Cash	£75.67		-£141.09
Portfolio cost	£98,385.97		+£581.40
Portfolio sell value (bid price - commission)	£59,569.92	(-39.5%)	+£6,132.16
Potential profits	£0		+£0
Yr 7 Dividends	£10,727.13		+£25.14
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£243.31		-£114.83
Yr 7 projected avg monthly profit	£1,382.43	(29.7%)	-£53.67
Total Dividends	£13,931.52		+£25.14
Total Interest	£0.20		+£0
Total Profit from sales	£23,967.94		-£114.83
Average monthly cash profit	£462.81	(9.9%)	-£2.47
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	66%		-1%

Quite a lot going on this week.

First of all I've changed my magic formula to remove P/E ratio as one of the ranking categories and replaced it with 3-year growth. I've decided just because a share is cheap doesn't mean I should buy it, but if a company is growing then it's worth buying even if not considered cheap. There is often a reason a share is cheap, as I've learned to my cost over the last 12 months. So my new ranking is based on 3-year growth rate, dividend yield, return on capital and smallest debt compared to pre-tax profit.

As a result of the change and from recent results, SMS:Smart Metering Systems dropped way out of the top 30 and I was almost at the 12 month review point, so I sold them. The others are still in the top 30. I sold my 107 shares for 842.5p making a loss of £114.83 (11.3%) but after dividends it will be around 7%.

The loss made a small dent in long term performance which dipped below 10%.

I bought 2,776 shares in OPTI:Optibiotix at 31.9p costing £897.49 with the proceeds. I wanted to reduce my average price a bit more while I can, and they appear to be having a re-rate after the Sweetbiotix news. Fingers crossed it was a good move as they are already 36.5p to sell which has made up for the SMS loss.

For a similar reason I added £400 to my AJ Bell SIPP and along with the cash in the account bought 1,692 more OPTI:Optibiotix shares at 32.5p costing £559.85.

There was also my monthly investment in APAX:Apax Global Alpha buying 74 shares at 171.51p costing £128.42

The purchases took my OPTI:Optibiotix holding to 186,963 costing £109,005.36. They are losing £40,809 at the moment, but now Sweetbiotix is kicking in there's hope this will improve.

I almost for got there was also a £25 dividend from PLUS:Plus500.

Back above the injection line

Still £40k of losses to make up, but now well above the trend line.

The trading account looks like this after week 312 overall and week 52 of year 6.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£707.08	(-62.3%)	-£24.35
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	-£711.28		+£0
Yr 6 projected avg monthly profit	-£59.27	(-37.9%)	+£1.17
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.98	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

A £24 drop thanks to JLP:Jubilee Metals in this disastrous account. The end of year 6 sees a dreadful performance of -£59 a month, wiping out nearly all my profits over the 6 years. We're left at just under £4 a month long term profit, which amazingly is still better than building society interest. The problem is the loss in value of what's left and the fact it will get a hell of a lot worse when DDDD:4D Pharma are wound up.

Cost is down after last week's sale, but is still higher than the injection, but value continues to drop.

I hope we can start to sneak up from here. I only have one active investment left so everything rides on JLP:Jubilee Metals.

We had two lots of amazing Sweetbiotix news this week but there should be a lot more to come. This announcement was for a new company which will still need to work with other companies to develop products. The big news we are waiting for is one of the existing 11 partners launching a product, which now the scientific paper has been produced could be imminent. Fingers crossed...

Week 361 Review - Best week for a very long time

I can't remember the last time there was a week as good as this, and it was based on no particular news. The gain was mainly down to an 8p rise in OPTI:Optibiotix, but a few other holdings did well too. The deficit between cost and value reduced by £15,276 to £86,523 and portfolio value increased to £96,331.

Biggest loser was JLP:Jubilee Metals, which was rather annoying as I chose this week to add some to my trading account. They dropped 9% and at 13.8p are way, way below the 20p I expected by now. 

As usual my curse struck again. I had a choice between more OPTI:Optibiotix shares or sensible magic formula shares when my SIPP transfer came through. Had I chosen OPTI I would be sitting on 30% gains, but I chose DNLM:Dunelm Group which is down 5% already.

SMS:Smart Metering Systems climbed 6% to be only 10% down, and I've had a 2% dividend with another one due soon so we're almost at break even.

SAE:Simec Atlantis Energy had confirmation that they were successful in a bid for contracts for difference and can now go ahead with more underwater turbines in the Pentland Firth. That could be a company saving announcement, and the shares climbed almost 100%, but for me that equated to 7% of my purchase price.

SBTX:SkinBioTherapeutics climbed 9% for no apparent reason, but are still 48% down.

Share of the Week is OPTI:Optibiotix by a long way. The 8p climb is 14% and covers most of the £15k rise this week.

Unfortunately still below the injection line, but a lot less depressing than last week.

Above the trend line at last!

Here's the ISA and shares portfolio after week 49 of year 7.

			Weekly Change
Cash	£0		-£6.43
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£42,484.15	(-48.8%)	+£7,448.18
Potential profits	£1,258.05		-£54.00
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,269.46	(34.4%)	-£27.12
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£474.63	(12.9%)	-£1.41
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Cash down to zero as I'd forgotten to remove a few monthly fees, in fact the trading account had to subsidize it a few quid to pay the last one. I should inject a bit more of a cash buffer after pay day. JLP:Jubilee Metals dropped so potential profits down by £54 but mainly a happy tale of huge gains in value.

Not quite above the injection line but we live in hope.

Well above the trend line. Let's hope this time it stays there.

The SIPP looks like this after week 345 overall and week 33 of year 7.

			Weekly Change
Cash	£216.76		-£237.02
Portfolio cost	£97,804.57		+£2,244.82
Portfolio sell value (bid price - commission)	£52,856.36	(-46.0%)	+£7,256.99
Potential profits	£0		+£0
Yr 7 Dividends	£10,701.99		+£7.80
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£358.14		+£0
Yr 7 projected avg monthly profit	£1,436.10	(31.1%)	-£45.26
Total Dividends	£13,906.38		+£8.80
Total Interest	£0.20		+£0
Total Profit from sales	£24,082.77		+£0
Average monthly cash profit	£465.28	(10.1%)	-£1.39
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	67%		-2%

My pension transfer came through so I did some buying. I was seriously considering buying more OPTI:Optibiotix but decided to stick to my plan for safe dividend paying shares. OPTI would have gained 30% in a few days whereas the shares I bought dropped in value.

I bought 121 shares in DNLM:Dunelm Group at 821.6992p costing £1,011.18 with commission and stamp duty. They promptly fell 5%. It scored well on my magic formula ranking, but after buying I did have a twinge of regret, as if inflation keeps going up then people may stop buying the big ticket items like sofas they sell. They have a string online presence so hopefully won't be tarnished with the same downturn other retail companies are having. Mind you, after writing that I'm wondering if I've made a mistake! I should have written this first...

I also bought another 555 shares in CAML:Central Asia Metals as it's my most well-run company and I want some more. They were 220.1242p and cost £1,233.64. They ended the week with a bid price of 220.5p so around the same as I bought them. They are about to become debt free and have lots of cash, so I am anticipating either a special dividend or another acquisition. I have no regrets buying these and should be buying more.

I had a £7.80 dividend from FXPO:Ferrexpo which takes their total dividends to £86.41 or 8%. It doesn't make up for the 76% drop in share price, but if they can hang on until Russia give up their war then the price may recover to pre-invasion levels.

As with the ISA, not quite back to the injection line

Not as far above the trend line as the ISA but back above it is good.

The trading account looks like this after week 311 overall and week 51 of year 6.

			Weekly Change
Cash	£43.18		-£216.56
Portfolio cost	£1,877.84		-£496.30
Portfolio sell value (bid price - commission)	£731.43	(-61.0%)	+£174.79
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	-£711.28		-£711.28
Yr 6 projected avg monthly profit	-£60.44	(-38.6%)	-£60.44
Dividends	£60.10		+£0
Profit from sales	£226.60		-£711.28
Average monthly cash profit	£3.99	(2.6%)	-£9.96
(Sold stocks profit + Dividends - Fees / Months)

I made a big decision to take a load of losses and starting again. My 2 lots of DDDD:4D Pharma shares are suspended until they sort out administration, after which I'll probably lose the lot. TALY:Tally still haven't floated again so are still suspended. It looks like if they do manage to re-float it will be in December. That left IQE:IQE which are not going anywhere for years, and HUM:Hummingbird Resources which are currently selling gold at a loss despite the high prices so are likely to go bust.

I realised if I baled out of both of those and added the proceeds to the cash I would have enough to buy one new £500 share. I sold IQE for a loss of £342.31 (67%) and HUM for a loss of £368.98 (70.9%). Absolute disaster and dropped my long term performance from 7.1% to 2.6%, but at least allowed me to start again.

I invested the cash in JLP:Jubilee Metals as they are ramping up production and there should be a very big hike in revenue in the next few months. It's not going to be a quick buy and sell but I think it's relatively safe and prevents me being tempted to take more profit from my main holding. They cost 14.375p each and I bought 3,478 for £511.91. Needless to say they are already down by 9% but most of that is wide spread and commission on such a small investment amount.

It's going to be very hard to get back up to my injection line now.

The good news from taking a big loss is the deficit comes down dramatically and this chart looks great.

For the first time in over a year I'm starting to feel a tiny spark of optimism. I wonder how long that will last!

Week 360 Review - A welcome creep upwards amongst the gloom

Nearly everything went down this week, but a 2p rise in OPTI:Optibiotix was enough to reduce the deficit between cost and value by £3,261 to £101,899 and increase portfolio value to £79,666. The fact that my dream objective is to reduce the deficit to under £100k shows how desperate I am at the moment.

SAE:Simec Atlantis Energy dropped 10% to go 85% down when it became obvious that unless they get a contract for difference to install some more tidal turbines next week, then they will probably go bust.

JLP:Jubilee Metals slipped another 7% of my purchase price, but any news on copper production is likely to see them put on a bit of a spurt.

Share of the Week is OPTI:Optibiotix because nothing else went up by 3% and they made me feel distinctly less miserable - not doubt until next week when the gains get wiped out again.

First decent tick upwards for a long time

Not good enough to get above the trend line though

Here's the ISA and shares portfolio after week 48 of year 7.

			Weekly Change
Cash	£6.43		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£35,035.97	(-57.7%)	+£1,742.89
Potential profits	£1,312.05		-£40.50
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,296.58	(35.2%)	-£27.59
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£476.04	(12.9%)	-£1.32
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

JLP:Jubilee Metals dropped again so potential profits down by £40, but a decent rise in value needs to happen every week for a year to claw back my losses.

Still a long way below the injection line

Given how steep the trend line has become, being underneath it is really bad.

The SIPP looks like this after week 344 overall and week 32 of year 7.

			Weekly Change
Cash	£453.78		+£147.49
Portfolio cost	£95,559.75		+£0
Portfolio sell value (bid price - commission)	£43,354.55	(-54.6%)	+£1,540.86
Potential profits	£0		+£0
Yr 7 Dividends	£10,694.19		+£15.39
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£358.14		+£0
Yr 7 projected avg monthly profit	£1,481.36	(33.3%)	-£45.63
Total Dividends	£13,898.58		+£15.39
Total Interest	£0.20		+£0
Total Profit from sales	£24,082.77		+£0
Average monthly cash profit	£466.67	(10.5%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	69%		+0%

Cash went up thanks to a tax rebate and me realising that all the recent dividends hadn't been added to the cash value. There was another £15 dividend, this time from FXPO:Ferrexpo, which is a relief as they are still able to function despite operating in Ukraine. Good increase in value, but still 54% down.

Closer to the injection line than the ISA, but not by much.

Still dragging the trend line steeper

The trading account looks like this after week 310 overall and week 50 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£556.64	(-76.6%)	-£21.88
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£13.95	(7.1%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

Yet another drop, and with only 2 of the 4 shares in the portfolio still trading I think drastic measures may be required to get this account working properly.

Woeful

Still below the trend line. This has been a stark lesson in how not to operate a trading account, so next week there's going to be fireworks.

Week 359 Review - Devastation as 4D Pharma goes into administration and new record low

The last few weeks have been really bad, in fact the last 12 months have been really bad, but when DDDD:4D Pharma suspended trading on Friday pending an announcement, things didn't looks good. They were not good, with a subsequent announcement that they had gone into administration after defaulting on the conditions of a loan and having no way to pay it back. This is my 2nd largest holding with around £18k invested which it looks like I'm going to lose.

Meanwhile there were lots of big drops and no shares increased by 5% or more, so the deficit between cost and value worsened by another £2,516 to £105,161 and took us to a new all-time low, with total value just £76,257.   

DDDD:4D Pharma had a big drop at the point they were suspended so fell 8% to go 88% down, but I suspect they will fall the other 12% as I am forced to write them off. The only vaguely good thing coming out of this is that I will lose about the same value as I got from the PBX:Probiotix shares dividend, so my overall performance will just go back to how it was before that. I will of course never go anywhere near junior pharma again after being wiped out twice.

APAX:Apax Global Alpha fell 6% after looking like it might get into profit for the last few weeks. They are now 10% down and looking less likely to get into profit.

CAML:Central Asia Metals continues to slide, falling 6% to go 7% down. The good news is I'm due a £2k pension transfer and I agreed with myself that half will go on CAML if they are still cheaper than I originally bought them, which is looking likely.

JLP:Jubilee Metals just can't get back above 15p and slipped another 5% this week.

Although no share made it above 5% this week, I will give Share of the Week to PLUS:Plus500, which climbed 3% and is only 1% down, so deserves a prize for giving me some hope in the current sea of misery.

When was the last time we went upwards?

Still dragging the trend line steeper downwards

Here's the ISA and shares portfolio after week 47 of year 7.

			Weekly Change
Cash	£6.43		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£33,293.08	(-59.8%)	-£1,073.04
Potential profits	£1,352.55		-£27.00
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,324.17	(35.9%)	-£28.79
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£477.36	(13.0%)	-£1.34
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Nothing to say other than this is bad.

I'm fed up of writing the same thing every week.


The SIPP looks like this after week 343 overall and week 31 of year 7.

			Weekly Change
Cash	£306.29		+£87.50
Portfolio cost	£95,559.75		+£0
Portfolio sell value (bid price - commission)	£41,813.69	(-56.2%)	-£1,386.47
Potential profits	£0		+£0
Yr 7 Dividends	£10,678.80		+£22.00
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£358.14		+£0
Yr 7 projected avg monthly profit	£1,526.99	(34.3%)	-£47.72
Total Dividends	£13,883.19		+£22.00
Total Interest	£0.20		+£0
Total Profit from sales	£24,082.77		+£0
Average monthly cash profit	£467.83	(10.5%)	-£1.09
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	69%		+0%

I got a tax rebate and a £22 dividend from ASY:Andrews Sykes Group, but aside from that the misery continues.

Same as ISA

Also same as ISA

The trading account looks like this after week 309 overall and week 49 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£578.52	(-75.6%)	-£56.85
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£14.00	(7.1%)	-£0.04
(Sold stocks profit + Dividends - Fees / Months)

When I write off 40% of my pot invested in DDDD:4D Pharma this account will be in desperate trouble.

Below the trend line so all hope is lost

I just can't go on like this for much longer. Surely something has to go right for once?